SAGE Therapeutics To Present At The Goldman, Sachs & Co. 37th Annual Global Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that Jeff Jonas, M.D., Chief Executive Officer of Sage, will present at the Goldman Sachs 37th Annual Global Healthcare Conference at 10:40 a.m. PT (1:40 p.m. ET) on Wednesday, June 8, 2016, in Rancho Palos Verdes, Calif. A live webcast of the presentation can be accessed on the investor page of Sage's website at investor.sagerx.com. A replay of the webcast will also be archived for up to 30 days on Sage's website following the conference.